CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,829,000 | +0.5% | 2,256,000 | +22.1% | 0.37% | -5.9% |
| Q3 2020 | $10,774,000 | -0.2% | 1,848,000 | +15.5% | 0.39% | -17.5% |
| Q2 2020 | $10,800,000 | +37.4% | 1,600,000 | +7900.0% | 0.47% | -9.0% |
| Q3 2019 | $7,860,000 | -76.1% | 20,000 | -99.1% | 0.52% | -74.9% |
| Q2 2019 | $32,946,000 | -36.8% | 2,215,600 | +5.5% | 2.08% | -27.2% |
| Q1 2019 | $52,122,000 | -42.4% | 2,100,000 | -58.3% | 2.85% | -58.4% |
| Q4 2018 | $90,447,000 | +88.2% | 5,036,000 | +207.8% | 6.86% | +137.7% |
| Q3 2018 | $48,049,000 | +69.3% | 1,636,000 | +162.2% | 2.88% | +55.6% |
| Q2 2018 | $28,373,000 | +14.8% | 624,000 | +33.3% | 1.85% | -2.0% |
| Q1 2018 | $24,710,000 | – | 468,000 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |